HC Solutions joins Tehnopol HealthTech Community 

HC Solutions, an Estonian company founded in 2012, has joined the Tehnopol HealthTech community. The company specialises in healthcare analytics and contributes to the introduction of innovative medical technologies to the market while improving the financing of healthcare systems. 

HC Solutions aims to provide data-driven solutions for analysing the cost-effectiveness and long-term trends of healthcare systems. Their services include economic viability assessments of healthcare services and technologies, data-driven forecasting, and market entry strategy development. The company primarily serves international medical technology firms, including pharmaceutical companies and medical device manufacturers. Impressively, over 56% of HC Solutions’ services are exported to foreign markets. 

Strategic consulting for market entry 

The company’s research and development efforts focus on two key areas: cost-effectiveness analysis of personalised medicine products and the development of alternative healthcare funding models. HC Solutions strives to ensure that Estonia has world-class access to innovative and efficient medical technologies. 

In addition to traditional healthcare analytics, HC Solutions has a dedicated division that supports the early-stage development of software-based and AI-powered medical devices. The company provides consulting on study planning, pricing strategy analysis, and regulatory and market conditions assessment to ensure the most seamless and cost-effective path to market entry. 

Innovation as a growth driver 

Innovation is at the heart of HC Solutions’ operations, as they work in a niche field where only a handful of smaller firms exist across Europe. They have successfully competed with major players, securing projects in analytical fields where others have failed. Their deep understanding of the industry, ability to identify trends, and innovative approach have given them a strong competitive advantage. 

Currently, HC Solutions is focusing on research initiatives aimed at helping clients more clearly demonstrate the value of their technologies to funders. They recognise that innovation plays a critical role, particularly for an Estonian company looking to sell high-value services or products internationally. In their sector, in-depth expertise and innovation are the two main drivers of successful sales. 

A world-class client base 

“We operate in a highly confidential industry, where most analyses involve products that have not yet been launched, making it difficult to share specific client feedback,” the company states. However, their client retention speaks for itself. HC Solutions has provided services to 70% of the world’s top 30 pharmaceutical companies, a significant portion of leading biotechnology firms, companies developing treatments for rare diseases, and medical device manufacturers. Many long-standing clients have worked with HC Solutions for over 10 years, with new clients joining each year. 

One of the company’s greatest achievements is assisting in securing public funding for over 100 medicines and medical technologies. They take the most pride in cases where their work has facilitated funding for innovative technologies or contributed to making treatments for rare diseases accessible. 

Expectations from the Tehnopol HealthTech community 

HC Solutions has high expectations for its collaboration with the Tehnopol HealthTech community. They see significant value in exchanging knowledge and experiences with community members and establishing new partnerships. Their primary interest lies in accelerating the growth of medical device manufacturers and advancing their research initiatives. 

Tehnopol welcomes HC Solutions into the community and looks forward to working together to drive innovation in health technology to new heights!